These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25273355)

  • 41. Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection.
    Melo R; Richer L; Johnson DL; Gomes-Solecki M
    PLoS One; 2016; 11(3):e0151850. PubMed ID: 26990760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outer surface protein OspC is an antiphagocytic factor that protects Borrelia burgdorferi from phagocytosis by macrophages.
    Carrasco SE; Troxell B; Yang Y; Brandt SL; Li H; Sandusky GE; Condon KW; Serezani CH; Yang XF
    Infect Immun; 2015 Dec; 83(12):4848-60. PubMed ID: 26438793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis.
    Hagman KE; Lahdenne P; Popova TG; Porcella SF; Akins DR; Radolf JD; Norgard MV
    Infect Immun; 1998 Jun; 66(6):2674-83. PubMed ID: 9596733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Enzyme immunoassay-based analysis of OspC recombinant proteins from Borrelia garinii and Borrelia afzelii isolated in West Siberia].
    Karavaev VS; Riabchenko AV; Beklemishev AB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (1):20-3. PubMed ID: 20218339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of human Lyme disease vaccine formulations in a mouse model.
    Telford SR; Kantor FS; Lobet Y; Barthold SW; Spielman A; Flavell RA; Fikrig E
    J Infect Dis; 1995 May; 171(5):1368-70. PubMed ID: 7751719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Borrelia burgdorferi sensu lato species in Europe induce diverse immune responses against C6 peptides in infected mice.
    Krupka I; Knauer J; Lorentzen L; O'Connor TP; Saucier J; Straubinger RK
    Clin Vaccine Immunol; 2009 Nov; 16(11):1546-62. PubMed ID: 19726618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis.
    Wilske B; Habermann C; Fingerle V; Hillenbrand B; Jauris-Heipke S; Lehnert G; Pradel I; Rössler D; Schulte-Spechtel U
    Med Microbiol Immunol; 1999 Dec; 188(3):139-44. PubMed ID: 10776844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato.
    Hauser U; Lehnert G; Lobentanzer R; Wilske B
    J Clin Microbiol; 1997 Jun; 35(6):1433-44. PubMed ID: 9163458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination against Lyme borreliosis.
    Wahlberg P
    Ann Med; 1999 Aug; 31(4):233-5. PubMed ID: 10480752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA.
    Fikrig E; Barthold SW; Kantor FS; Flavell RA
    J Infect Dis; 1991 Dec; 164(6):1224-7. PubMed ID: 1955724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A flagella-less mutant of Borrelia burgdorferi as a live attenuated vaccine in the murine model of Lyme disease.
    Sadziene A; Thompson PA; Barbour AG
    J Infect Dis; 1996 May; 173(5):1184-93. PubMed ID: 8627071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
    Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
    Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and purification of recombinant outer surface protein A (rOspA) of Borrelia burgdorferi sensu stricto and Borrelia afzelii.
    Bĕláková J; Krupka M; Sebestová M; Tuhácková J; Vrzal V; Raska M; Weigl E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):257-9. PubMed ID: 16601765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testing of the Biocan B inj. ad us. vet. vaccine and development of the new recombinant vaccine against canine borreliosis.
    Tuhácková J; Bĕláková J; Krupka M; Neperený J; Chumela J; Weigl E; Vrzal V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):297-302. PubMed ID: 16601776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.
    Padilla ML; Callister SM; Schell RF; Bryant GL; Jobe DA; Lovrich SD; DuChateau BK; Jensen JR
    J Infect Dis; 1996 Oct; 174(4):739-46. PubMed ID: 8843211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure of a heterologous recombinant Sca5/OmpB protein-based vaccine to elicit effective protective immunity against Rickettsia rickettsii infections in C3H/HeN mice.
    Riley SP; Cardwell MM; Chan YG; Pruneau L; Del Piero F; Martinez JJ
    Pathog Dis; 2015 Dec; 73(9):ftv101. PubMed ID: 26519448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disulfide-mediated oligomer formation in Borrelia burgdorferi outer surface protein C, a critical virulence factor and potential Lyme disease vaccine candidate.
    Earnhart CG; Rhodes DV; Marconi RT
    Clin Vaccine Immunol; 2011 Jun; 18(6):901-6. PubMed ID: 21525304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
    Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
    Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi.
    Barthold SW; Feng S; Bockenstedt LK; Fikrig E; Feen K
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S9-17. PubMed ID: 9233658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.